Argentine Hospitals’ Research on COVID-19 Vaccine Effects: PAHO Recognition

Argentine Hospitals’ Research on COVID-19 Vaccine Effects: PAHO Recognition

Title: Argentine Hospital Recognized for Contribution to COVID-19 Vaccine Study Subtitle: Luis Lagomaggiore Hospital in Mendoza among the outstanding hospitals nationwide Date: June 20, 2023 During the COVID-19 pandemic, healthcare systems worldwide faced immense challenges. Hospitals and health centers had to adapt and implement strategies to provide effective care while also engaging in research and … Read more

Frexalimab Shows Strikingly Positive Results in Treatment of Relapsing Multiple Sclerosis

Frexalimab, a second-generation anti-CD40L antibody, has shown “strikingly positive” effects in treating relapsing multiple sclerosis (MS), significantly reducing disease activity without depleting B cells. The drug is a novel, second-generation monoclonal antibody designed to block the costimulatory CD40/CD40L cellular pathway, the mechanism of which is believed to potentially modify T-and B-cell activation and innate immune … Read more